首页> 外文期刊>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association >Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis
【24h】

Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis

机译:肝硬化患者自体外周血干细胞移植的长期结果

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND & AIMS: Peripheral blood stem cells (PBSCs) mobilized with colony-stimulating factor can promote liver regeneration and increase liver function in patients with liver diseases. However, the long-term effects of stem cell treatments on survival and risk of hepatocellular carcinoma (HCC) in patients with cirrhosis have not been determined. We investigated the long-term effects of autologous stem cell transplantation and risk of HCC in patients with cirrhosis.
机译:背景&AIMS:用菌落刺激因子动员的外周血干细胞(PBSC)可以促进肝脏再生并增加肝病患者的肝功能。 然而,尚未确定干细胞治疗肝硬化患者肝细胞癌(HCC)对肝细胞癌(HCC)的生存和风险的长期影响。 我们调查了肝硬化患者自体干细胞移植和HCC风险的长期影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号